Efficacy and safety of single-agent sunitinib in treating patients with advanced hepatocelluar carcinoma after sorafenib failure: A prospective, open-label, phase II study.
T. Yau
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
R. C. Leung
No relevant relationships to disclose
H. Wong
No relevant relationships to disclose
J. Chiu
No relevant relationships to disclose
P. Chan
No relevant relationships to disclose
R. Pang
No relevant relationships to disclose
S. T. Fan
No relevant relationships to disclose
R. T. P. Poon
Consultant or Advisory Role - Pfizer
Honoraria - Pfizer
Research Funding - Pfizer